IBB - iShares NASDAQ Biotechnology Index Fund Summary, Stock Quote and News | Benzinga

Market Overview

109.09 -0.53 (-0.48%)

Data as of Oct 24, 2018

Prev. Close 109.62
Price Open 108.08
Volume 2,522,595
Day's Range 106.52 - 110.39
52 Wk Range -
50 Day Moving Avg. 117.18
PE Ratio 0
Shares Outstanding
Market Cap

Trade IBB stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares Shanthi RexalineTue, 23 Oct 2018 08:35:24 -0400
11 Stocks That Moved From ESMO 2018 Shanthi RexalineMon, 22 Oct 2018 13:39:00 -0400
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs Shanthi RexalineSun, 21 Oct 2018 17:15:32 -0400
The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut Shanthi RexalineFri, 19 Oct 2018 08:28:26 -0400
The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs Shanthi RexalineThu, 18 Oct 2018 07:56:42 -0400
The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise Shanthi RexalineWed, 17 Oct 2018 08:15:53 -0400
The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist Shanthi RexalineTue, 16 Oct 2018 08:52:07 -0400
Drug Companies To Disclose Pricing Information In Ads Shanthi RexalineMon, 15 Oct 2018 15:38:31 -0400
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs Shanthi RexalineSun, 14 Oct 2018 13:21:15 -0400
The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program Shanthi RexalineFri, 12 Oct 2018 07:34:03 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Strongbridge Biopharma plc Added to the NASDAQ Biotech Index Globe NewswireDec 13, 2017
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index Business WireDec 11, 2017
BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF Business WireNov 07, 2017
MediciNova Added to NASDAQ Biotechnology Index Globe NewswireDec 14, 2016
Blueprint Medicines Added to NASDAQ Biotechnology Index PRNewswireDec 17, 2015
Collegium Added to the NASDAQ Biotechnology Index Globe NewswireDec 14, 2015
Vitae Pharmaceuticals Announces Addition to the NASDAQ Biotechnology Index Globe NewswireDec 14, 2015
GW Pharmaceuticals Added to NASDAQ Biotechnology Index Globe NewswireDec 22, 2014
Revance Therapeutics Added to NASDAQ Biotechnology Index Globe NewswireDec 18, 2014
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) Globe NewswireDec 18, 2014
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Biotech Stocks Bloodied But Can Now Drive M&A Seeking Alpha4 days ago
FDA issues new guidance aimed at more efficient drug development Seeking AlphaOct 15, 2018
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? ZacksOct 08, 2018
The Biotech Conundrum Seeking AlphaOct 05, 2018
Rates beginning to matter? Tech leads declines Seeking AlphaOct 04, 2018
Healthcare And Biotechnology Dashboard - Update Seeking AlphaOct 03, 2018
5%+ Dividend Yield Portfolio: Ignore The Political Circus (September 2018 Review) Seeking AlphaOct 02, 2018
FDA issues new draft guidance aimed at speedier generic approvals Seeking AlphaOct 02, 2018
EM And High Vol: Beware Of A Falling Knife Seeking AlphaOct 02, 2018
How Libtayo's Approval May Help Cure Regeneron's Remaining Ills Seeking AlphaOct 01, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Brokerage Center

Compare All Online Brokerages